We are excited to spotlight Dr. Maryam Lustberg as a leading figure in breast cancer treatment and supportive care in oncology.
Dr. Maryam Lustberg is the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, as well as the Chief of Breast Medical Oncology at Yale Cancer Center. She has received numerous accolades, including being named one of the top breast medical oncologists in the nation by Forbes and earning a place on the Castle Connolly list of “Regional Top Doctors” and “Exceptional Women in Medicine” for 2020.
In addition to her clinical roles, Dr. Lustberg is actively involved in professional oncology organizations. She serves as the President of the Multinational Association of Supportive Care in Cancer (MASCC) and is a member of several key committees, including the ASCO Annual Meeting Education Committee and the Patient and Survivor Care Education Committee. Dr. Lustberg is also an Associate Editor for the Journal of Cancer Survivorship.
Follow Dr. Maryam Lustberg on X/Twitter and LinkedIn to stay updated on her contributions to breast cancer care, patient advocacy, and supportive oncology practices.
About Dr. Maryam Lustberg
Dr. Maryam Lustberg is a highly respected breast medical oncologist known for her patient-centered approach and leadership in oncology. As the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center, she provides cutting-edge treatment and compassionate care to breast cancer patients.
Her extensive contributions to cancer research, patient survivorship, and supportive care have earned her numerous recognitions, including being featured as a Forbes top breast oncologist and listed as one of the “Exceptional Women in Medicine.” Dr. Lustberg continues to lead innovations in the field while also serving on the Board of Directors for MASCC, further advancing supportive care standards worldwide.
Stay tuned for more profiles of OncoInfluencers and explore our website to discover other influential voices in the oncology and global health communities.
